5 days ago
President Donald Trump has been in the White House for nearly six years, spanning two nonconsecutive terms. Over that time, the iconic Dow Jones Industrial Average (DJINDICES:^DJI), benchmark S&P 500 (SNPINDEX:^GSPC), and growth-dependent Nasdaq Composite (NASDAQINDEX:^IXIC) have delivered well-above-average annual returns, compared to most other presidents since the late 1890s.
One of the key catalysts powering Wall Street's bull market, the artificial intelligence (AI) infrastructure build-out, was well underway before Trump's second term began. But make no mistake about it: Wall Street and investors have also benefited immensely from the president's Tax Cuts and Jobs Act (signed into law in December 2017), which lowered the peak marginal corporate income tax rate to 21% (the lowest rate since 1939), fueling record S&P 500 share buybacks.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
President Trump's tariff and trade policy may be doing more harm than good. Image source: Official White House Photo by Molly Riley.
President Trump has also made tariffs a huge part of his economic growth plan. Said Trump,
#Trump #NVIDIA #white #House
One of the key catalysts powering Wall Street's bull market, the artificial intelligence (AI) infrastructure build-out, was well underway before Trump's second term began. But make no mistake about it: Wall Street and investors have also benefited immensely from the president's Tax Cuts and Jobs Act (signed into law in December 2017), which lowered the peak marginal corporate income tax rate to 21% (the lowest rate since 1939), fueling record S&P 500 share buybacks.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
President Trump's tariff and trade policy may be doing more harm than good. Image source: Official White House Photo by Molly Riley.
President Trump has also made tariffs a huge part of his economic growth plan. Said Trump,
#Trump #NVIDIA #white #House
29 days ago
Apple's 2.5B active devices and 1.5B paid subscriptions let it monetize AI without heavy data center spending, fueling a 9th straight EPS beat.
Microsoft's AI infrastructure spending surged 79% to $116B, shrinking free cash flow, while Apple's customers fund AI hardware themselves.
Siri AI awaits EU and China approval, iCloud+ upgrades haven't launched yet, and a $30B Broadcom chip deal gives Apple untapped upside catalysts.
Read More: Learn 7 ways to generate income with a $1,000,000+ portfolio (sponsor)
I added to my Apple (NASDAQ:AAPL) position this month and expect to add more after the October 29 earnings report. The market has misunderstood Apple's AI strategy.
#Apple #broadcom
Microsoft's AI infrastructure spending surged 79% to $116B, shrinking free cash flow, while Apple's customers fund AI hardware themselves.
Siri AI awaits EU and China approval, iCloud+ upgrades haven't launched yet, and a $30B Broadcom chip deal gives Apple untapped upside catalysts.
Read More: Learn 7 ways to generate income with a $1,000,000+ portfolio (sponsor)
I added to my Apple (NASDAQ:AAPL) position this month and expect to add more after the October 29 earnings report. The market has misunderstood Apple's AI strategy.
#Apple #broadcom
2 months ago
Though it's down by 33% over the last five years, Ethereum (CRYPTO: ETH) climbed from about $130 in early 2020 to over $4,800 in early November 2021, which would have been sufficient to turn an investment of $27,000 into about $1 million. It's natural for investors to wonder if another historic run is in the cards for the coin, given that it's more widely known now than it was then.
Today, with a market cap of $292 billion as of Sept. 15, Ethereum can still grow your wealth substantially, but it probably won't be a millionaire maker for those with small positions anytime soon. Let's first look at the math to see why, then examine its upcoming catalysts.
Missed AI's "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our **** ysts, we're only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
Ethereum isn't going to be a millionaire-maker investment from here, even if you're willing to pony up a lot more capital than most investors have on hand or are willing to allocate to a lottery ticket, and even if it becomes the next cryptocurrency to explode.
Turning $10,000 into $1 million requires a 100x gain, which would boost Ethereum's market cap to $29.2 trillion.
#even
Today, with a market cap of $292 billion as of Sept. 15, Ethereum can still grow your wealth substantially, but it probably won't be a millionaire maker for those with small positions anytime soon. Let's first look at the math to see why, then examine its upcoming catalysts.
Missed AI's "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our **** ysts, we're only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
Ethereum isn't going to be a millionaire-maker investment from here, even if you're willing to pony up a lot more capital than most investors have on hand or are willing to allocate to a lottery ticket, and even if it becomes the next cryptocurrency to explode.
Turning $10,000 into $1 million requires a 100x gain, which would boost Ethereum's market cap to $29.2 trillion.
#even
2 months ago
Cybersecurity provider CrowdStrike Holdings, Inc. (NASDAQ:CRWD)'s shares are up by more than 100% year to date. With AI continuing to dominate the market narrative, the firm has found itself at the center of the industry's concerns about cybersecurity. While some, such as Anthropic's Dario Amodei, have claimed that their AI software is sufficient for cybersecurity purposes, others have argued that firms such as CrowdStrike Holdings, Inc. (NASDAQ:CRWD) will play a key role in the industry. Cramer is in the latter camp, and in his morning appearance on September 15th, the CNBC TV host discussed the recent discussions about AI being a threat:
"I had George Kurtz last night, who has partnered both with OpenAI and Anthropic. And he encouraged me to say look, they are doing a lot of things about safeguards. I think he was so much surprised, that there was so much doomsaying, of course, doomsaying being heavily refuted. Now there's a stock, remember that stock was up the most of any stock in the S&P."
While Cramer believes CrowdStrike Holdings, Inc. (NASDAQ:CRWD) will play an important role in cybersecurity in the AI era, the broader debate about the firm is about its AI-driven cybersecurity initiatives and whether they are sufficient to stay competitive and justify the eye-watering share price performance. On this front, the firm's annual recurring revenue (ARR) grew by 25% and net new ARR grew by 55% in its fiscal second quarter. Additionally, CrowdStrike Holdings, Inc. (NASDAQ:CRWD)'s net new ARR set a new record of $333 million. Cramer's bullishness on the firm is also matched by others, such as ******* ysts from Argus. Argus has set a $425 share price target for CrowdStrike Holdings, Inc. (NASDAQ:CRWD) and argued that growth in agentic AI use presents a major tailwind for the firm.
Yet, in a classic case of the bigger you are, the harder you fall, CrowdStrike Holdings, Inc. (NASDAQ:CRWD)'s massive growth creates risk. For its fiscal second quarter, the firm has guided net new ARR to range between $343 million and $347 million to imply growth ranging between 29% to 31%. Considering that the metric grew by 55% in Q1, the new figures do indicate a slowdown. As for catalysts from agentic AI, CrowdStrike Holdings, Inc. (NASDAQ:CRWD)'s next-gen SIEM (Security Information and Event Management) ending ARR grew by 60% to $695 million in the second quarter.
Hedge fund interest in CrowdStrike Holdings, Inc. (NASDAQ:CRWD) grew in Q2. According to Insider Monkey's data, 89 out of 1,006 funds had held a stake in the firm during the period. This marked a jump over the 89 out of the 1,022 funds in Q1. As for valuation, CrowdStrike Holdings, Inc. (NASDAQ:CRWD)'s forward P/E ratio of 188 is significantly higher than peer firm Palo Alto's 89 which should increase the pressure to maintain growth. Short interest as a percentage of float is 2.41% for CrowdStrike Holdings, Inc. (NASDAQ:CRWD) compared to 2.65% for Palo Alto.
#NASDAQ #firm #grew
"I had George Kurtz last night, who has partnered both with OpenAI and Anthropic. And he encouraged me to say look, they are doing a lot of things about safeguards. I think he was so much surprised, that there was so much doomsaying, of course, doomsaying being heavily refuted. Now there's a stock, remember that stock was up the most of any stock in the S&P."
While Cramer believes CrowdStrike Holdings, Inc. (NASDAQ:CRWD) will play an important role in cybersecurity in the AI era, the broader debate about the firm is about its AI-driven cybersecurity initiatives and whether they are sufficient to stay competitive and justify the eye-watering share price performance. On this front, the firm's annual recurring revenue (ARR) grew by 25% and net new ARR grew by 55% in its fiscal second quarter. Additionally, CrowdStrike Holdings, Inc. (NASDAQ:CRWD)'s net new ARR set a new record of $333 million. Cramer's bullishness on the firm is also matched by others, such as ******* ysts from Argus. Argus has set a $425 share price target for CrowdStrike Holdings, Inc. (NASDAQ:CRWD) and argued that growth in agentic AI use presents a major tailwind for the firm.
Yet, in a classic case of the bigger you are, the harder you fall, CrowdStrike Holdings, Inc. (NASDAQ:CRWD)'s massive growth creates risk. For its fiscal second quarter, the firm has guided net new ARR to range between $343 million and $347 million to imply growth ranging between 29% to 31%. Considering that the metric grew by 55% in Q1, the new figures do indicate a slowdown. As for catalysts from agentic AI, CrowdStrike Holdings, Inc. (NASDAQ:CRWD)'s next-gen SIEM (Security Information and Event Management) ending ARR grew by 60% to $695 million in the second quarter.
Hedge fund interest in CrowdStrike Holdings, Inc. (NASDAQ:CRWD) grew in Q2. According to Insider Monkey's data, 89 out of 1,006 funds had held a stake in the firm during the period. This marked a jump over the 89 out of the 1,022 funds in Q1. As for valuation, CrowdStrike Holdings, Inc. (NASDAQ:CRWD)'s forward P/E ratio of 188 is significantly higher than peer firm Palo Alto's 89 which should increase the pressure to maintain growth. Short interest as a percentage of float is 2.41% for CrowdStrike Holdings, Inc. (NASDAQ:CRWD) compared to 2.65% for Palo Alto.
#NASDAQ #firm #grew
2 months ago
Crypto markets and related stocks moved lower Tuesday as investors braced for two major Washington catalysts: a Senate vote on the CLARITY Act and the Federal Reserve's interest-rate decision Wednesday.
Bitcoin was trading around $76,431, down 2.19% over 24 hours, while Ether fell 1.8% to roughly $2,449 and Solana dropped 1.02% to about $100. The total crypto market capitalization declined 1.2% to $2.61 trillion.
Derivatives traders were also caught in the selloff. Roughly $384 million in crypto positions were liquidated over 24 hours, including about $195 million in longs and $189 million in shorts, while nearly $160 million was wiped out over the previous 12 hours.
Crypto-linked stocks were hit harder.
Related: CLARITY Act faces urgent Democratic counterproposal and growing opposition
#hours #tuesday
Bitcoin was trading around $76,431, down 2.19% over 24 hours, while Ether fell 1.8% to roughly $2,449 and Solana dropped 1.02% to about $100. The total crypto market capitalization declined 1.2% to $2.61 trillion.
Derivatives traders were also caught in the selloff. Roughly $384 million in crypto positions were liquidated over 24 hours, including about $195 million in longs and $189 million in shorts, while nearly $160 million was wiped out over the previous 12 hours.
Crypto-linked stocks were hit harder.
Related: CLARITY Act faces urgent Democratic counterproposal and growing opposition
#hours #tuesday
2 months ago
Broyhill **** et Management, a Charlotte-based firm, issued its second-quarter 2026 investor letter, which is available for download here. The Broyhill Equity Composite gained 8.8% in Q2, trailing the MSCI All Country World Index's 15.1% and the MSCI ACWI Value Index's 10.8%. For the first half, the Composite returned 2.3%, versus 11.5% for the Index. The letter highlights that a significant portion of the shortfall occurred in April due to market dynamics and geopolitical events, with tech, particularly semiconductors, driving recent gains. Broyhill notes its lack of direct semiconductor exposure but acknowledges potential interest in the sector if opportunities arise, maintaining its investment philosophy focused on capital protection in fragile market conditions. Also, check the fund's top five holdings to see its best picks in 2026.
In its second-quarter 2026 investor letter, Broyhill **** et Management highlighted First Citizens BancShares, Inc. (NASDAQ:FCNCA). First Citizens BancShares, Inc. (NASDAQ:FCNCA) operates as the holding company for First-Citizens Bank & Trust Company, providing retail and commercial banking services. On September 14, 2026, First Citizens BancShares, Inc. (NASDAQ:FCNCA) closed at $2,173.88 per share. Over the past month, First Citizens BancShares, Inc. (NASDAQ:FCNCA) declined 1.03%, but its shares are up 17.10% over the past year. First Citizens BancShares, Inc. (NASDAQ:FCNCA) has a market capitalization of $24.55 billion, and its stock has traded within a 52-week range of $1,623.76 to $2,296.30.
Broyhill **** et Management stated the following regarding First Citizens BancShares, Inc. (NASDAQ:FCNCA) in its Q2 2026 investor letter:
"First Citizens BancShares, Inc. (NASDAQ:FCNCA), initiated in June, is a well-run company which we believe to be undervalued and with catalysts on the horizon. The company has retired almost 20% of its Class A shares since July 2024, and inside its roughly $25 billion market capitalization sits a rail leasing fleet of approximately 128,000 cars valued by the market at bank multiples. Management has proven themselves highly competent and highly aligned with shareholders, with the Holding family in key executive positions, owning over 20% of the economics and controlling roughly half the vote through their Class B shares. Much of what we are waiting on has a date attached to it: two separations have completed, and Masco and First Citizens are retiring shares at a pace that improves per-share value whether or not the multiples change."
#fcnca #market
In its second-quarter 2026 investor letter, Broyhill **** et Management highlighted First Citizens BancShares, Inc. (NASDAQ:FCNCA). First Citizens BancShares, Inc. (NASDAQ:FCNCA) operates as the holding company for First-Citizens Bank & Trust Company, providing retail and commercial banking services. On September 14, 2026, First Citizens BancShares, Inc. (NASDAQ:FCNCA) closed at $2,173.88 per share. Over the past month, First Citizens BancShares, Inc. (NASDAQ:FCNCA) declined 1.03%, but its shares are up 17.10% over the past year. First Citizens BancShares, Inc. (NASDAQ:FCNCA) has a market capitalization of $24.55 billion, and its stock has traded within a 52-week range of $1,623.76 to $2,296.30.
Broyhill **** et Management stated the following regarding First Citizens BancShares, Inc. (NASDAQ:FCNCA) in its Q2 2026 investor letter:
"First Citizens BancShares, Inc. (NASDAQ:FCNCA), initiated in June, is a well-run company which we believe to be undervalued and with catalysts on the horizon. The company has retired almost 20% of its Class A shares since July 2024, and inside its roughly $25 billion market capitalization sits a rail leasing fleet of approximately 128,000 cars valued by the market at bank multiples. Management has proven themselves highly competent and highly aligned with shareholders, with the Holding family in key executive positions, owning over 20% of the economics and controlling roughly half the vote through their Class B shares. Much of what we are waiting on has a date attached to it: two separations have completed, and Masco and First Citizens are retiring shares at a pace that improves per-share value whether or not the multiples change."
#fcnca #market
2 months ago
Broyhill ******* et Management, a Charlotte-based firm, issued its second-quarter 2026 investor letter, which is available for download here. The Broyhill Equity Composite gained 8.8% in Q2, trailing the MSCI All Country World Index's 15.1% and the MSCI ACWI Value Index's 10.8%. For the first half, the Composite returned 2.3%, versus 11.5% for the Index. The letter highlights that a significant portion of the shortfall occurred in April due to market dynamics and geopolitical events, with tech, particularly semiconductors, driving recent gains. Broyhill notes its lack of direct semiconductor exposure but acknowledges potential interest in the sector if opportunities arise, maintaining its investment philosophy focused on capital protection in fragile market conditions. Also, check the fund's top five holdings to see its best picks in 2026.
In its second-quarter 2026 investor letter, Broyhill ******* et Management highlighted First Citizens BancShares, Inc. (NASDAQ:FCNCA). First Citizens BancShares, Inc. (NASDAQ:FCNCA) operates as the holding company for First-Citizens Bank & Trust Company, providing retail and commercial banking services. On September 14, 2026, First Citizens BancShares, Inc. (NASDAQ:FCNCA) closed at $2,173.88 per share. Over the past month, First Citizens BancShares, Inc. (NASDAQ:FCNCA) declined 1.03%, but its shares are up 17.10% over the past year. First Citizens BancShares, Inc. (NASDAQ:FCNCA) has a market capitalization of $24.55 billion, and its stock has traded within a 52-week range of $1,623.76 to $2,296.30.
Broyhill ******* et Management stated the following regarding First Citizens BancShares, Inc. (NASDAQ:FCNCA) in its Q2 2026 investor letter:
"First Citizens BancShares, Inc. (NASDAQ:FCNCA), initiated in June, is a well-run company which we believe to be undervalued and with catalysts on the horizon. The company has retired almost 20% of its Class A shares since July 2024, and inside its roughly $25 billion market capitalization sits a rail leasing fleet of approximately 128,000 cars valued by the market at bank multiples. Management has proven themselves highly competent and highly aligned with shareholders, with the Holding family in key executive positions, owning over 20% of the economics and controlling roughly half the vote through their Class B shares. Much of what we are waiting on has a date attached to it: two separations have completed, and Masco and First Citizens are retiring shares at a pace that improves per-share value whether or not the multiples change."
#first #fcnca
In its second-quarter 2026 investor letter, Broyhill ******* et Management highlighted First Citizens BancShares, Inc. (NASDAQ:FCNCA). First Citizens BancShares, Inc. (NASDAQ:FCNCA) operates as the holding company for First-Citizens Bank & Trust Company, providing retail and commercial banking services. On September 14, 2026, First Citizens BancShares, Inc. (NASDAQ:FCNCA) closed at $2,173.88 per share. Over the past month, First Citizens BancShares, Inc. (NASDAQ:FCNCA) declined 1.03%, but its shares are up 17.10% over the past year. First Citizens BancShares, Inc. (NASDAQ:FCNCA) has a market capitalization of $24.55 billion, and its stock has traded within a 52-week range of $1,623.76 to $2,296.30.
Broyhill ******* et Management stated the following regarding First Citizens BancShares, Inc. (NASDAQ:FCNCA) in its Q2 2026 investor letter:
"First Citizens BancShares, Inc. (NASDAQ:FCNCA), initiated in June, is a well-run company which we believe to be undervalued and with catalysts on the horizon. The company has retired almost 20% of its Class A shares since July 2024, and inside its roughly $25 billion market capitalization sits a rail leasing fleet of approximately 128,000 cars valued by the market at bank multiples. Management has proven themselves highly competent and highly aligned with shareholders, with the Holding family in key executive positions, owning over 20% of the economics and controlling roughly half the vote through their Class B shares. Much of what we are waiting on has a date attached to it: two separations have completed, and Masco and First Citizens are retiring shares at a pace that improves per-share value whether or not the multiples change."
#first #fcnca
2 months ago
Apple (AAPL) recently decided to buy startup Sonera, which has reportedly developed a neural-data technology tool. The move could boost Apple stock within the next few years and bodes well for the company's long-term outlook. In the medium term, however, AAPL stock is unlikely to surpass the returns of the Nasdaq-100 by a significant margin, as the company continues to face multiple, negative catalysts. Weaker-than-expected revenue-growth guidance for the current quarter also suggests that these factors are beginning to weigh on Apple's performance. Let's take a closer look.
Earlier this year, Apple agreed to buy California-based startup called Sonera, which the European Commission disclosed on Sept. 8. The startup reportedly utilizes "breakthrough sensing technology" which allows it to ***** yze human brains without making direct contact with individuals' bodies.
Dear ***** eX Stock Fans, Mark Your Calendars for September 21
How to Play IBM Stock as It Teams Up with NASA to Launch a New Open-Source Model
GF Securities Says NAND Prices May Stabilize Later This Year. What This Means for Sandisk Stock.
#Apple
Earlier this year, Apple agreed to buy California-based startup called Sonera, which the European Commission disclosed on Sept. 8. The startup reportedly utilizes "breakthrough sensing technology" which allows it to ***** yze human brains without making direct contact with individuals' bodies.
Dear ***** eX Stock Fans, Mark Your Calendars for September 21
How to Play IBM Stock as It Teams Up with NASA to Launch a New Open-Source Model
GF Securities Says NAND Prices May Stabilize Later This Year. What This Means for Sandisk Stock.
#Apple
2 months ago
On September 3, AbbVie Inc. (NYSE:ABBV) finalized its acquisition of clinical-stage biotech Apogee Therapeutics, Inc. (NASDAQ:APGE) for $135.11 per share in cash. The $10.9 billion buyouts immediately fold Apogee's promising inflammatory and immunology (I&I) pipeline into AbbVie's commercial engine. On the exact same day, AbbVie separately reported positive Phase 3 Cervino trial results for its bispecific T-cell engager, etentamig, in relapsed/refractory multiple myeloma. Together, the dual catalysts emphasize how mega-cap pharmaceutical giants are deploying cash flow from legacy franchises to lock in next-generation immunology and oncology ***** ets.
In Q2 2026, AbbVie Inc. (NYSE:ABBV) posted $16.99 billion in net revenue, up 10.2% year over year, while adjusted diluted EPS increased 22.9% to $3.65. Growth was driven by its immunology blockbusters, Skyrizi and Rinvoq, which generated $5.505 billion and $2.525 billion in revenue, respectively, representing growth of 24.4% and 24.5%. These gains more than offset the continued decline in Humira revenue, which fell 35.9% to $756 million amid biosimilar competition. AbbVie reiterated its full-year 2026 adjusted EPS guidance of $13.87–$14.07, including a $0.14 dilutive impact from the Apogee transaction.
As a clinical-stage biotech, Apogee Therapeutics, Inc. (NASDAQ:APGE) generated no product revenue in Q2 2026, while R&D expenses reached $67.3 million and G&A expenses totaled $24.3 million, resulting in a quarterly net loss of $85.9 million. Despite the cash burn, the company maintained a strong liquidity position, with $1.3 billion in cash and marketable securities, alongside a $1.3 billion non-dilutive credit collaboration with Blackstone Life Sciences to support Phase 3 trials of its lead ***** et, zumilokibart.
Financially, AbbVie is vastly superior in immediate cash generation and profitability, whereas Apogee represented pure clinical optionality backed by robust liquidity.
For AbbVie, acquiring Apogee's optimized antibody portfolio, including zumilokibart for atopic dermatitis, strengthens its post-Humira immunology franchise. Combined with internal R&D advances such as etentamig, which achieved statistically significant overall response rate and progression-free survival results in the Phase 3 Cervino study, along with an 87.9% 12-month overall survival rate, AbbVie demonstrates potential to sustain strong organic growth.
#phase #revenue #Growth
In Q2 2026, AbbVie Inc. (NYSE:ABBV) posted $16.99 billion in net revenue, up 10.2% year over year, while adjusted diluted EPS increased 22.9% to $3.65. Growth was driven by its immunology blockbusters, Skyrizi and Rinvoq, which generated $5.505 billion and $2.525 billion in revenue, respectively, representing growth of 24.4% and 24.5%. These gains more than offset the continued decline in Humira revenue, which fell 35.9% to $756 million amid biosimilar competition. AbbVie reiterated its full-year 2026 adjusted EPS guidance of $13.87–$14.07, including a $0.14 dilutive impact from the Apogee transaction.
As a clinical-stage biotech, Apogee Therapeutics, Inc. (NASDAQ:APGE) generated no product revenue in Q2 2026, while R&D expenses reached $67.3 million and G&A expenses totaled $24.3 million, resulting in a quarterly net loss of $85.9 million. Despite the cash burn, the company maintained a strong liquidity position, with $1.3 billion in cash and marketable securities, alongside a $1.3 billion non-dilutive credit collaboration with Blackstone Life Sciences to support Phase 3 trials of its lead ***** et, zumilokibart.
Financially, AbbVie is vastly superior in immediate cash generation and profitability, whereas Apogee represented pure clinical optionality backed by robust liquidity.
For AbbVie, acquiring Apogee's optimized antibody portfolio, including zumilokibart for atopic dermatitis, strengthens its post-Humira immunology franchise. Combined with internal R&D advances such as etentamig, which achieved statistically significant overall response rate and progression-free survival results in the Phase 3 Cervino study, along with an 87.9% 12-month overall survival rate, AbbVie demonstrates potential to sustain strong organic growth.
#phase #revenue #Growth
2 months ago
TeraWulf fell 4% to $16.50, APLD dropped 3%, and IREN slid 2%, all on broad profit-taking after strong YTD gains with no new company catalysts.
The Bitcoin mining ETF WGMI dropped 4% while QQQ fell just 0.4%, confirming the selloff is a group rotation, not broad tech weakness.
Paul Meeks initiated TeraWulf with a Buy and $19 target, while a 20-year Anthropic deal worth $19 billion in contracted revenue remains fully intact.
Just released. Our ******* ysts combed the entire stock market and named the ten best stocks to buy right now, and Iren didn't make the cut. Enter your email to see the names that beat IREN. The report is free. Enter your email and see if any of your stocks made the cut.
Shares of TeraWulf (NASDAQ:WULF) are down 4% to $16.50 in Thursday's midday session, trimming a slice of what's been a 43.6% year-to-date advance for the stock. The pullback is showing up across the miner-turned-AI-infrastructure cohort, and there's no fresh company disclosure to pin it on.
#enter #broad
The Bitcoin mining ETF WGMI dropped 4% while QQQ fell just 0.4%, confirming the selloff is a group rotation, not broad tech weakness.
Paul Meeks initiated TeraWulf with a Buy and $19 target, while a 20-year Anthropic deal worth $19 billion in contracted revenue remains fully intact.
Just released. Our ******* ysts combed the entire stock market and named the ten best stocks to buy right now, and Iren didn't make the cut. Enter your email to see the names that beat IREN. The report is free. Enter your email and see if any of your stocks made the cut.
Shares of TeraWulf (NASDAQ:WULF) are down 4% to $16.50 in Thursday's midday session, trimming a slice of what's been a 43.6% year-to-date advance for the stock. The pullback is showing up across the miner-turned-AI-infrastructure cohort, and there's no fresh company disclosure to pin it on.
#enter #broad
0.00$ raised of 0.00$ goal
0 donations
0.00$
to go
2 months ago
Boring investing strategies aren't always bad. While some people look for hidden opportunities that no one is considering, the best investments may be hidden in plain sight.
That's why my boring prediction is that AI stocks will continue to rally. These stocks aren't exactly the greatest-kept secrets. Nvidia (NASDAQ: NVDA) has grown into the world's most valuable publicly traded company in recent years. More investors are also looking toward smaller AI stocks instead of just relying on chipmakers, which is the same approach I have used for my portfolio.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
It may be boring to hear yet another person advocate for AI stocks, but the technology's evolution and upcoming catalysts suggest that this approach is still solid.
AI investors should carefully monitor Nvidia and Broadcom (NASDAQ: AVGO) when ****** sing how far the AI rally can go. This has been true for years. While I have been bullish about AI stocks for years, their recent results have increased my resolve.
#NVIDIA #continue
That's why my boring prediction is that AI stocks will continue to rally. These stocks aren't exactly the greatest-kept secrets. Nvidia (NASDAQ: NVDA) has grown into the world's most valuable publicly traded company in recent years. More investors are also looking toward smaller AI stocks instead of just relying on chipmakers, which is the same approach I have used for my portfolio.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
It may be boring to hear yet another person advocate for AI stocks, but the technology's evolution and upcoming catalysts suggest that this approach is still solid.
AI investors should carefully monitor Nvidia and Broadcom (NASDAQ: AVGO) when ****** sing how far the AI rally can go. This has been true for years. While I have been bullish about AI stocks for years, their recent results have increased my resolve.
#NVIDIA #continue
2 months ago
Technip Energies (THNPY) stock has declined by 22.5% in the last 52 weeks, with the Middle East conflict a key negative catalyst. As a result of this correction, Technip stock trades at an attractive forward price-earnings ratio of 18.
While geopolitical tensions in the Middle East persist, there are emerging catalysts for Technip. It was recently reported that Technip is a contender for a potential $10 billion rocket fuel deal with **** eX (SPCX). With the first Starship launch targeted for 2029, Elon Musk has been pushing for rapid construction, and a potential deal for Technip would imply healthy revenue growth over the next 36 months. It's therefore not surprising that this news translated into a sharp rally for THNPY stock.
Fears of an Extended US-Iran Conflict Boost Crude Oil Prices
Nat-Gas Prices Rise on Hotter US Weather and Expectations of Smaller Storage
Crude Oil Prices Supported by Escalation of US-Iran Hostilities
#prices #Iran #conflict
While geopolitical tensions in the Middle East persist, there are emerging catalysts for Technip. It was recently reported that Technip is a contender for a potential $10 billion rocket fuel deal with **** eX (SPCX). With the first Starship launch targeted for 2029, Elon Musk has been pushing for rapid construction, and a potential deal for Technip would imply healthy revenue growth over the next 36 months. It's therefore not surprising that this news translated into a sharp rally for THNPY stock.
Fears of an Extended US-Iran Conflict Boost Crude Oil Prices
Nat-Gas Prices Rise on Hotter US Weather and Expectations of Smaller Storage
Crude Oil Prices Supported by Escalation of US-Iran Hostilities
#prices #Iran #conflict
2 months ago
Key Takeaways
Tom Lee said Ethereum could reach $6,000 if Bitcoin climbs to $150,000 and the ETH/BTC ratio rises to 0.04.
The BitMine chairman believes the CLARITY Act will accelerate institutional adoption.
Lee identified demand from Asia and institutional performance-chasing as additional catalysts for ETH.
Ethereum could climb to $6,000 under what Tom Lee says is a "conservative" market scenario, with the BitMine chairman arguing that the token remains significantly undervalued despite its recent rebound.
#ethereum #asia
Tom Lee said Ethereum could reach $6,000 if Bitcoin climbs to $150,000 and the ETH/BTC ratio rises to 0.04.
The BitMine chairman believes the CLARITY Act will accelerate institutional adoption.
Lee identified demand from Asia and institutional performance-chasing as additional catalysts for ETH.
Ethereum could climb to $6,000 under what Tom Lee says is a "conservative" market scenario, with the BitMine chairman arguing that the token remains significantly undervalued despite its recent rebound.
#ethereum #asia
2 months ago
Oracle (ORCL) is giving investors a fresh reason to revisit its cloud and artificial intelligence (AI) growth story after a brutal selloff pushed the stock sharply lower. Citi has now placed Oracle on an upside 90-day catalyst watch, maintaining a "Buy" rating and a $330 price target, arguing that the recent decline may have created an attractive entry point.
The bullish case centers on Oracle's cloud business, where strong artificial intelligence (AI) infrastructure demand could drive better-than-expected growth, pricing, and profitability. Citi also sees Oracle's upcoming earnings report and investor day in late October as potential catalysts for renewed investor confidence and upward estimate revisions. With the company having added around $85 billion sequentially in remaining performance obligations (RPO) in its May quarter, it remains to be seen whether accelerating AI demand can help the cloud business regain Wall Street's attention and give ORCL stock room to rebound.
Wu-Tang Clan Member Raekwon Is a Palantir 'OG,' Visiting Headquarters 16 Years After Receiving His Custom PLTR Jacket
Tesla Stock Could Benefit as Trump Locks Down the U.S. Power Grid
Tesla Just Killed Its Solar Roof After Years of Struggling to Scale. What It Means for TSLA Stock.
#cloud #citi
The bullish case centers on Oracle's cloud business, where strong artificial intelligence (AI) infrastructure demand could drive better-than-expected growth, pricing, and profitability. Citi also sees Oracle's upcoming earnings report and investor day in late October as potential catalysts for renewed investor confidence and upward estimate revisions. With the company having added around $85 billion sequentially in remaining performance obligations (RPO) in its May quarter, it remains to be seen whether accelerating AI demand can help the cloud business regain Wall Street's attention and give ORCL stock room to rebound.
Wu-Tang Clan Member Raekwon Is a Palantir 'OG,' Visiting Headquarters 16 Years After Receiving His Custom PLTR Jacket
Tesla Stock Could Benefit as Trump Locks Down the U.S. Power Grid
Tesla Just Killed Its Solar Roof After Years of Struggling to Scale. What It Means for TSLA Stock.
#cloud #citi
2 months ago
Resumed U.S.-Iran strikes sent oil up 3%, lifting CVX and XOM roughly 1.5% each at Monday's open as Middle East risk premiums returned.
OXY fully offset Middle East production losses via Permian volumes, while PCG collapsed 19% after California lawmakers blocked wildfire liability reform.
Trump's Venezuela deal covers 65 billion barrels, but degraded infrastructure means years of investment separate the reserves announcement from actual new supply.
Act now: the ***** yst who called NVIDIA in 2010 just named his top 10 AI stocks — and Exxon Mobil didn't make the cut. Grab the names FREE today.
Energy stocks led the market higher Monday morning as two major oil catalysts hit at once. CNBC's Dominic Chu framed the setup on the network's opening segment on Monday: "Oil prices did jump by about 3% on the resumption of those attacks, and that sent energy stocks higher."
#resumed
OXY fully offset Middle East production losses via Permian volumes, while PCG collapsed 19% after California lawmakers blocked wildfire liability reform.
Trump's Venezuela deal covers 65 billion barrels, but degraded infrastructure means years of investment separate the reserves announcement from actual new supply.
Act now: the ***** yst who called NVIDIA in 2010 just named his top 10 AI stocks — and Exxon Mobil didn't make the cut. Grab the names FREE today.
Energy stocks led the market higher Monday morning as two major oil catalysts hit at once. CNBC's Dominic Chu framed the setup on the network's opening segment on Monday: "Oil prices did jump by about 3% on the resumption of those attacks, and that sent energy stocks higher."
#resumed
2 months ago
You can make money in any stock market. Luckily, you only have to prepare for bullish and bearish markets. While each market has different catalysts that determine the bullishness or bearishness of the current trend, knowing how to navigate these markets can open the doors to higher returns.
I optimize my portfolio and investment decisions to increase the probability of making money. It's not a guarantee, but having a game plan for each market type is better than being unprepared. Here's how I navigate bull and bear markets.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
I like Warren Buffett's mentality of buying and holding companies for multiple years rather than buying shares and then strategically exiting after an earnings report. Those moves sound flashy when they work, but they can also backfire. Even if you win those types of trades, you incur short-term capital gains, which are taxed less favorably than long-term capital gains.
Knowing what a company does, which catalysts will influence its stock price, and what it did in its recent earnings is vital before making any investment. You need this information to outperform the S&P 500 in both bearish and bullish markets.
#markets #NVIDIA #money #bearish
I optimize my portfolio and investment decisions to increase the probability of making money. It's not a guarantee, but having a game plan for each market type is better than being unprepared. Here's how I navigate bull and bear markets.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
I like Warren Buffett's mentality of buying and holding companies for multiple years rather than buying shares and then strategically exiting after an earnings report. Those moves sound flashy when they work, but they can also backfire. Even if you win those types of trades, you incur short-term capital gains, which are taxed less favorably than long-term capital gains.
Knowing what a company does, which catalysts will influence its stock price, and what it did in its recent earnings is vital before making any investment. You need this information to outperform the S&P 500 in both bearish and bullish markets.
#markets #NVIDIA #money #bearish
2 months ago
In a recent interview on CNBC's Halftime Report, Josh Brown, CEO of Ritholtz Wealth Management, highlighted Incyte (NASDAQ: INCY) and Biogen (NASDAQ: BIIB) as two of his "Best Stocks in the Market." Brown said he wanted to focus on stocks that had "nothing to do" with the AI and data-center spending theme.
"We wanted to do something that had nothing to do with data centers and GPUs and just take a break from that whole AI capex world that we've been living in for so long," Brown said. "We wanted to talk about stocks that are working away from that."
Brown likes Biogen because of strong fundamentals and the company's strong earnings performance.
But in this article, we will focus on Incyte, which is up 22% so far this year.
Brown's bullish case for Incyte centers on its strong earnings momentum and expanding drug pipeline. Brown said the company has a pipeline of roughly nine or 10 drugs at various stages of development, creating multiple potential catalysts for future growth.
#focus #data
"We wanted to do something that had nothing to do with data centers and GPUs and just take a break from that whole AI capex world that we've been living in for so long," Brown said. "We wanted to talk about stocks that are working away from that."
Brown likes Biogen because of strong fundamentals and the company's strong earnings performance.
But in this article, we will focus on Incyte, which is up 22% so far this year.
Brown's bullish case for Incyte centers on its strong earnings momentum and expanding drug pipeline. Brown said the company has a pipeline of roughly nine or 10 drugs at various stages of development, creating multiple potential catalysts for future growth.
#focus #data
2 months ago
First Phosphate Corp. (CSE:PHOS, NASDAQ:PHOS, FRA:KD0, OTCQX:FRSPF) earlier this week provided an update on the advancement of its Bégin-Lamarche property, with CEO John Passalacqua highlighting an expanded mineral resource, its NASDAQ uplisting and access to more than $50 million of capital as the company works towards its next development milestones.
Speaking to Proactive, Passalacqua said the updated NI 43-101 mineral resource estimate showed a significant increase in indicated resources and an increase in the volume of material.
He said the most important feature was the "continuity and consistency throughout the entire resource", adding that the update had given First Phosphate confidence to move into a feasibility study as soon as possible.
The feasibility study represents one of the company's key upcoming potential catalysts. Passalacqua said First Phosphate was targeting its release by the end of 2026 or early 2027, with permitting and an investment decision targeted by the end of 2027.
First Phosphate's recent NASDAQ uplisting could also broaden its access to US investors. Passalacqua said the company's American depositary receipt had been uplisted to the exchange, with its management team and board subsequently taking part in the opening bell ceremony in New York.
#passalacqua #phosphate #NASDAQ #access
Speaking to Proactive, Passalacqua said the updated NI 43-101 mineral resource estimate showed a significant increase in indicated resources and an increase in the volume of material.
He said the most important feature was the "continuity and consistency throughout the entire resource", adding that the update had given First Phosphate confidence to move into a feasibility study as soon as possible.
The feasibility study represents one of the company's key upcoming potential catalysts. Passalacqua said First Phosphate was targeting its release by the end of 2026 or early 2027, with permitting and an investment decision targeted by the end of 2027.
First Phosphate's recent NASDAQ uplisting could also broaden its access to US investors. Passalacqua said the company's American depositary receipt had been uplisted to the exchange, with its management team and board subsequently taking part in the opening bell ceremony in New York.
#passalacqua #phosphate #NASDAQ #access
2 months ago
When investors want to play the AI power boom, the first names that come to mind are hot stocks in emerging energy technologies, such as advanced fuel cell maker Bloom Energy (NYSE:BE) and small modular reactor developer Oklo (NYSE:OKLO). Bloom has major AI partnerships with Oracle and Brookfield, while Oklo has deals with Meta Platforms and Switch.
One company almost no one is talking about is the high-yielding clean-power producer Clearway Energy (NYSE:CWEN). That's a mistake. Its parent (Clearway Energy Group) quietly signed a nearly 1.2-gigawatt (GW) deal to build renewable power for Alphabet (NASDAQ:GOOG)(NASDAQ:GOOGL), and it's getting paid much more for the power produced at some of its legacy ***** ets because the new power buyer is a hyperscaler with voracious energy needs.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
That's only the beginning. AI power is one of the catalysts that make Clearway among the top renewable energy stocks to buy.
Image source: Getty Images.
#NYSE #bloom
One company almost no one is talking about is the high-yielding clean-power producer Clearway Energy (NYSE:CWEN). That's a mistake. Its parent (Clearway Energy Group) quietly signed a nearly 1.2-gigawatt (GW) deal to build renewable power for Alphabet (NASDAQ:GOOG)(NASDAQ:GOOGL), and it's getting paid much more for the power produced at some of its legacy ***** ets because the new power buyer is a hyperscaler with voracious energy needs.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
That's only the beginning. AI power is one of the catalysts that make Clearway among the top renewable energy stocks to buy.
Image source: Getty Images.
#NYSE #bloom
2 months ago
Morgan Stanley is forecasting that Cisco (CSCO) could be entering a new period of lasting growth. According to **** yst Meta Marshall, the company appears to be entering a "more durable growth phase," as quoted by Seeking Alpha. The firm also has an "Overweight" rating on the tech giant with a price target of $135. Fueling that call are several key catalysts, including upgrades with networking equipment, demand for artificial intelligence, and cybersecurity.
One of the biggest catalysts for Morgan Stanley's bullishness is that Cisco's customers are still in the early stages of upgrading their networking equipment. As of now, Marshall says that only about 7% of Cisco's Catalyst 4K and 6K (switches that are used by companies to connect computers, phones, servers, and other devices together) have been updated so far. That means there are still plenty of other companies that will need to upgrade.
Walmart Stock Is More Expensive Than Nvidia Amid Earnings Miss
SpaceX Stock Just Crashed Below Its IPO Price: Here's the Bull Case **** ody Can Ignore
A Major Bitcoin Short Squeeze Is Taking MicroStrategy Stock Higher. What Comes Next.
#morgan #Growth #catalysts
One of the biggest catalysts for Morgan Stanley's bullishness is that Cisco's customers are still in the early stages of upgrading their networking equipment. As of now, Marshall says that only about 7% of Cisco's Catalyst 4K and 6K (switches that are used by companies to connect computers, phones, servers, and other devices together) have been updated so far. That means there are still plenty of other companies that will need to upgrade.
Walmart Stock Is More Expensive Than Nvidia Amid Earnings Miss
SpaceX Stock Just Crashed Below Its IPO Price: Here's the Bull Case **** ody Can Ignore
A Major Bitcoin Short Squeeze Is Taking MicroStrategy Stock Higher. What Comes Next.
#morgan #Growth #catalysts
2 months ago
Treasury Secretary Scott Bessent moved fast to calm the bond market this month. Two of the biggest names on Wall Street just moved just as fast to say it probably will not be enough. A rebuttal that landed within days of his own announcement.
The pushback lands at an awkward moment for Bessent. The national debt just hit a fresh milestone and a closely watched Federal Reserve speech is only days away. Both developments raise the stakes for whatever the Treasury decides to do next.
Interest rate strategists at Goldman Sachs and Wells Fargo both said the Treasury Department's expanded bond buybacks will do little to reverse the recent jump in long-term yields. Rates on 10- and 30-year Treasuries briefly dropped after the announcement, then rose again, erasing much of the initial relief, Bloomberg reported.
Goldman Sachs strategists George Cole and William Marshall wrote in an August 21 research note that the buyback expansion "does not address what we see as the main sources of recent long-end volatility." They added that the buybacks are "unlikely to meaningfully reset rate levels even if scaled up."
Wells Fargo strategists led by Erik Nelson made a similar case in their own August 21 note, arguing that lowering long-end yields would require macroeconomic shifts rather than Treasury market operations. They pointed to a slowdown in growth and inflation, less uncertainty around Federal Reserve policy, fiscal consolidation, or a decline in investment-grade corporate bond issuance as the kinds of catalysts actually needed to move yields lower.
#strategists
The pushback lands at an awkward moment for Bessent. The national debt just hit a fresh milestone and a closely watched Federal Reserve speech is only days away. Both developments raise the stakes for whatever the Treasury decides to do next.
Interest rate strategists at Goldman Sachs and Wells Fargo both said the Treasury Department's expanded bond buybacks will do little to reverse the recent jump in long-term yields. Rates on 10- and 30-year Treasuries briefly dropped after the announcement, then rose again, erasing much of the initial relief, Bloomberg reported.
Goldman Sachs strategists George Cole and William Marshall wrote in an August 21 research note that the buyback expansion "does not address what we see as the main sources of recent long-end volatility." They added that the buybacks are "unlikely to meaningfully reset rate levels even if scaled up."
Wells Fargo strategists led by Erik Nelson made a similar case in their own August 21 note, arguing that lowering long-end yields would require macroeconomic shifts rather than Treasury market operations. They pointed to a slowdown in growth and inflation, less uncertainty around Federal Reserve policy, fiscal consolidation, or a decline in investment-grade corporate bond issuance as the kinds of catalysts actually needed to move yields lower.
#strategists
3 months ago
Some offers on this page are from advertisers who pay us, which may affect which products we write about, but not our recommendations. See our Advertiser Disclosure.
Silver (SI=F) September futures opened at $63.43 per ounce on Wednesday, August 19, 2026, down 1% from Tuesday's closing price. The silver price moved higher this morning, reaching $65 as of 8:55 a.m. ET.
Despite signs of strength Wednesday morning, the silver price is down about 9% for the year — after spiking in late January and then dipping into negative territory in March. Catalysts have included ongoing tensions in the Middle East and higher rate hike expectations. While the war in Iran is ongoing, the interest-rate outlook has improved. Silver has not meaningfully appreciated, however.
The metal's industrial applications add complexity to its price drivers relative to gold. As a result, silver tends to be far more volatile. The current gold-to-silver ratio near 68 is in line with the long-term average range of 50 and 80.
The opening price of silver futures on Wednesday, August 19, 2026, was 1% lower compared to Tuesday's closing price. Here's how today's opening silver price has changed versus last week, month, and year:
#silver #closing
Silver (SI=F) September futures opened at $63.43 per ounce on Wednesday, August 19, 2026, down 1% from Tuesday's closing price. The silver price moved higher this morning, reaching $65 as of 8:55 a.m. ET.
Despite signs of strength Wednesday morning, the silver price is down about 9% for the year — after spiking in late January and then dipping into negative territory in March. Catalysts have included ongoing tensions in the Middle East and higher rate hike expectations. While the war in Iran is ongoing, the interest-rate outlook has improved. Silver has not meaningfully appreciated, however.
The metal's industrial applications add complexity to its price drivers relative to gold. As a result, silver tends to be far more volatile. The current gold-to-silver ratio near 68 is in line with the long-term average range of 50 and 80.
The opening price of silver futures on Wednesday, August 19, 2026, was 1% lower compared to Tuesday's closing price. Here's how today's opening silver price has changed versus last week, month, and year:
#silver #closing
3 months ago
Some offers on this page are from advertisers who pay us, which may affect which products we write about, but not our recommendations. See our Advertiser Disclosure.
Silver (SI=F) September futures opened at $63.43 per ounce on Wednesday, August 19, 2026, down 1% from Tuesday's closing price. The silver price moved higher this morning, reaching $65 as of 8:55 a.m. ET.
Despite signs of strength Wednesday morning, the silver price is down about 9% for the year — after spiking in late January and then dipping into negative territory in March. Catalysts have included ongoing tensions in the Middle East and higher rate hike expectations. While the war in Iran is ongoing, the interest-rate outlook has improved. Silver has not meaningfully appreciated, however.
The metal's industrial applications add complexity to its price drivers relative to gold. As a result, silver tends to be far more volatile. The current gold-to-silver ratio near 68 is in line with the long-term average range of 50 and 80.
The opening price of silver futures on Wednesday, August 19, 2026, was 1% lower compared to Tuesday's closing price. Here's how today's opening silver price has changed versus last week, month, and year:
#morning
Silver (SI=F) September futures opened at $63.43 per ounce on Wednesday, August 19, 2026, down 1% from Tuesday's closing price. The silver price moved higher this morning, reaching $65 as of 8:55 a.m. ET.
Despite signs of strength Wednesday morning, the silver price is down about 9% for the year — after spiking in late January and then dipping into negative territory in March. Catalysts have included ongoing tensions in the Middle East and higher rate hike expectations. While the war in Iran is ongoing, the interest-rate outlook has improved. Silver has not meaningfully appreciated, however.
The metal's industrial applications add complexity to its price drivers relative to gold. As a result, silver tends to be far more volatile. The current gold-to-silver ratio near 68 is in line with the long-term average range of 50 and 80.
The opening price of silver futures on Wednesday, August 19, 2026, was 1% lower compared to Tuesday's closing price. Here's how today's opening silver price has changed versus last week, month, and year:
#morning
3 months ago
Some offers on this page are from advertisers who pay us, which may affect which products we write about, but not our recommendations. See our Advertiser Disclosure.
Silver (SI=F) September futures opened at $63.43 per ounce on Wednesday, August 19, 2026, down 1% from Tuesday's closing price. The silver price moved higher this morning, reaching $65 as of 8:55 a.m. ET.
Despite signs of strength Wednesday morning, the silver price is down about 9% for the year — after spiking in late January and then dipping into negative territory in March. Catalysts have included ongoing tensions in the Middle East and higher rate hike expectations. While the war in Iran is ongoing, the interest-rate outlook has improved. Silver has not meaningfully appreciated, however.
The metal's industrial applications add complexity to its price drivers relative to gold. As a result, silver tends to be far more volatile. The current gold-to-silver ratio near 68 is in line with the long-term average range of 50 and 80.
The opening price of silver futures on Wednesday, August 19, 2026, was 1% lower compared to Tuesday's closing price. Here's how today's opening silver price has changed versus last week, month, and year:
#silver #price #august
Silver (SI=F) September futures opened at $63.43 per ounce on Wednesday, August 19, 2026, down 1% from Tuesday's closing price. The silver price moved higher this morning, reaching $65 as of 8:55 a.m. ET.
Despite signs of strength Wednesday morning, the silver price is down about 9% for the year — after spiking in late January and then dipping into negative territory in March. Catalysts have included ongoing tensions in the Middle East and higher rate hike expectations. While the war in Iran is ongoing, the interest-rate outlook has improved. Silver has not meaningfully appreciated, however.
The metal's industrial applications add complexity to its price drivers relative to gold. As a result, silver tends to be far more volatile. The current gold-to-silver ratio near 68 is in line with the long-term average range of 50 and 80.
The opening price of silver futures on Wednesday, August 19, 2026, was 1% lower compared to Tuesday's closing price. Here's how today's opening silver price has changed versus last week, month, and year:
#silver #price #august
3 months ago
Ondas Holdings and Unusual Machines dropped between 7 and 8 percent as four drone stocks fell in sync, pointing to a theme unwind rather than stock-specific catalysts.
Kratos Defense fell 5% despite sitting down 20% YTD, with 30-year Treasury yields near 19-year highs amplifying pressure on high-multiple drone stocks.
Act now: the ******* yst who called NVIDIA in 2010 just named his top 10 AI stocks — and Red Cat Holdings didn't make the cut. Grab the names FREE today.
The defense drone complex is selling off together on Thursday morning, and the shape of the move matters more than the headline attached to it. Ondas Holdings (NASDAQ:ONDS) stock is down 7% to $8.31, while Unusual Machines (NYSE:UMAC) stock is down 8% to $26.13.
Meanwhile, Red Cat Holdings (NASDAQ:RCAT) stock is down 5% to $9.36, and Kratos Defense & Security Solutions (NASDAQ:KTOS) stock is down 5% to $57.61. Four names that entered the day with wildly different year-to-date setups are all falling by similar amounts, which points to positioning as the driver.
#drone
Kratos Defense fell 5% despite sitting down 20% YTD, with 30-year Treasury yields near 19-year highs amplifying pressure on high-multiple drone stocks.
Act now: the ******* yst who called NVIDIA in 2010 just named his top 10 AI stocks — and Red Cat Holdings didn't make the cut. Grab the names FREE today.
The defense drone complex is selling off together on Thursday morning, and the shape of the move matters more than the headline attached to it. Ondas Holdings (NASDAQ:ONDS) stock is down 7% to $8.31, while Unusual Machines (NYSE:UMAC) stock is down 8% to $26.13.
Meanwhile, Red Cat Holdings (NASDAQ:RCAT) stock is down 5% to $9.36, and Kratos Defense & Security Solutions (NASDAQ:KTOS) stock is down 5% to $57.61. Four names that entered the day with wildly different year-to-date setups are all falling by similar amounts, which points to positioning as the driver.
#drone
3 months ago
Apple Inc. (NASDAQ:AAPL) received a major vote of confidence from Rothschild Redburn today, with the firm upgrading the stock from Neutral to "Buy" and raising its price target to $400 from $260. The upgrade rests on two major catalysts for Apple: its entry into premium foldables and a strategic reset to the Apple Intelligence platform.
Apple's bull case lies within its tight integration of premium hardware, proprietary silicon, and its rapidly expanding services layer. For the near future, **** yst James Cordwell anticipates iPhone sales to grow at a 12% five-year annual compound rate, roughly 3-14% above consensus expectations between fiscal 2026 and 2030.
This anticipated increase is backed by Apple's potential entry into the premium foldables market, particularly with the launch of iPhone Ultra. Not only will Apple gain a new product category with the launch, but will also be able to lift its average selling prices for the broader iPhone lineup.
This thesis is backed by numbers. The **** yst firm noted how Apple already boasts a base of 2.55 billion devices, supported by a degree of customer retention only few competitors can rival.
The second part of Apple's bull thesis, according to the firm, is its Services business. The firm believes that it is the most valuable part of Apple's franchise, growing at roughly three times the rate of Products. The business generates gross margins of roughly 75%, more than double of that earned on Product sales.
#firm #product #entry
Apple's bull case lies within its tight integration of premium hardware, proprietary silicon, and its rapidly expanding services layer. For the near future, **** yst James Cordwell anticipates iPhone sales to grow at a 12% five-year annual compound rate, roughly 3-14% above consensus expectations between fiscal 2026 and 2030.
This anticipated increase is backed by Apple's potential entry into the premium foldables market, particularly with the launch of iPhone Ultra. Not only will Apple gain a new product category with the launch, but will also be able to lift its average selling prices for the broader iPhone lineup.
This thesis is backed by numbers. The **** yst firm noted how Apple already boasts a base of 2.55 billion devices, supported by a degree of customer retention only few competitors can rival.
The second part of Apple's bull thesis, according to the firm, is its Services business. The firm believes that it is the most valuable part of Apple's franchise, growing at roughly three times the rate of Products. The business generates gross margins of roughly 75%, more than double of that earned on Product sales.
#firm #product #entry
3 months ago
Greenhaven Road Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The fund achieved an approximate 11% net return in the second quarter, indicating progress from the first quarter. Key changes to the portfolio will include lower concentration and increased investments with near-term catalysts, alongside a proactive stance on profit-taking. The focus will remain on owning strong businesses and conducting research that challenges consensus views, as several major investments are poised for significant events within the year. Despite declines in market multiples, underlying businesses continue to grow, suggesting a favorable positioning for returns. Additionally, reviewing the Fund's top five holdings could help identify its best picks for 2026.
In its Q2 2026 investor letter, Greenhaven Road Capital highlighted Liquidia Corporation (NASDAQ:LQDA). Liquidia Corporation (NASDAQ:LQDA) is a biopharmaceutical company, focusing on developing therapies for rare cardiopulmonary diseases. On August 14, 2026, Liquidia Corporation (NASDAQ:LQDA) closed at $74.44 per share. One-month return of Liquidia Corporation (NASDAQ:LQDA) was 0.26% and its shares gained 178.79% over the past 52 weeks. Liquidia Corporation (NASDAQ:LQDA) has a market capitalization of $6.66 billion.
Greenhaven Road Capital stated the following regarding Liquidia Corporation (NASDAQ:LQDA) in its Q2 2026 investor letter:
"Liquidia Corporation (NASDAQ:LQDA) — This is another special situation. The company has launched a successful drug but remains in a patent dispute that will determine how large their market can be. We purchased shares below where I believed they would settle even after an adverse trial outcome. The shares appreciated more than 30% before a verdict, so we realized a short-term gain and will revisit the investment after the decision."
Liquidia Corporation (NASDAQ:LQDA) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 41 hedge fund portfolios held Liquidia Corporation (NASDAQ:LQDA) at the end of the first quarter which was 44 in the previous quarter. While we acknowledge the potential of Liquidia Corporation (NASDAQ:LQDA) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#corporation
In its Q2 2026 investor letter, Greenhaven Road Capital highlighted Liquidia Corporation (NASDAQ:LQDA). Liquidia Corporation (NASDAQ:LQDA) is a biopharmaceutical company, focusing on developing therapies for rare cardiopulmonary diseases. On August 14, 2026, Liquidia Corporation (NASDAQ:LQDA) closed at $74.44 per share. One-month return of Liquidia Corporation (NASDAQ:LQDA) was 0.26% and its shares gained 178.79% over the past 52 weeks. Liquidia Corporation (NASDAQ:LQDA) has a market capitalization of $6.66 billion.
Greenhaven Road Capital stated the following regarding Liquidia Corporation (NASDAQ:LQDA) in its Q2 2026 investor letter:
"Liquidia Corporation (NASDAQ:LQDA) — This is another special situation. The company has launched a successful drug but remains in a patent dispute that will determine how large their market can be. We purchased shares below where I believed they would settle even after an adverse trial outcome. The shares appreciated more than 30% before a verdict, so we realized a short-term gain and will revisit the investment after the decision."
Liquidia Corporation (NASDAQ:LQDA) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 41 hedge fund portfolios held Liquidia Corporation (NASDAQ:LQDA) at the end of the first quarter which was 44 in the previous quarter. While we acknowledge the potential of Liquidia Corporation (NASDAQ:LQDA) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#corporation
3 months ago
Greenhaven Road Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The fund achieved an approximate 11% net return in the second quarter, indicating progress from the first quarter. Key changes to the portfolio will include lower concentration and increased investments with near-term catalysts, alongside a proactive stance on profit-taking. The focus will remain on owning strong businesses and conducting research that challenges consensus views, as several major investments are poised for significant events within the year. Despite declines in market multiples, underlying businesses continue to grow, suggesting a favorable positioning for returns. Additionally, reviewing the Fund's top five holdings could help identify its best picks for 2026.
In its Q2 2026 investor letter, Greenhaven Road Capital highlighted AppLovin Corporation (NASDAQ:APP). AppLovin Corporation (NASDAQ:APP) is a mobile technology company specializing in developing software-based platforms for advertisers to enhance the marketing and monetization of their content. On August 14, 2026, AppLovin Corporation (NASDAQ:APP) closed at $315.44 per share, reflecting a market capitalization of $105.97 billion. AppLovin Corporation (NASDAQ:APP) posted a one-month return of -25.71%, while its shares lost 28.07% over the past 52 weeks.
Greenhaven Road Capital stated the following regarding AppLovin Corporation (NASDAQ:APP) in its Q2 2026 investor letter:
"AppLovin Corporation (NASDAQ:APP) — This is a 1% position in a small AI basket. AppLovin is an AI company whose product happens to be ad matching. AXON predicts which ad to show to which user to maximize conversion AppLovin has been one of the best companies at using AI at scale to drive revenues and profits. In 2025 revenue grew ~70% year-over-year to $5.48B with ~82% adjusted EBITDA margin and $3.95B of free cash flow (FCF), an 88% conversion of EBITDA to FCF. In 2025 the company was a rule of 142 company with 70% revenue growth and 72% FCF margin. AppLovin should generate more than $6 million of EBITDA per employee in 2026, paring down headcount while growing at very high rates. Shares trade at sub 20X 2027 FCF."
AppLovin Corporation (NASDAQ:APP) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 91 hedge fund portfolios held AppLovin Corporation (NASDAQ:APP) at the end of the first quarter, compared to 108 in the previous quarter. While we acknowledge the potential of AppLovin Corporation (NASDAQ:APP) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#applovin #company #ebitda
In its Q2 2026 investor letter, Greenhaven Road Capital highlighted AppLovin Corporation (NASDAQ:APP). AppLovin Corporation (NASDAQ:APP) is a mobile technology company specializing in developing software-based platforms for advertisers to enhance the marketing and monetization of their content. On August 14, 2026, AppLovin Corporation (NASDAQ:APP) closed at $315.44 per share, reflecting a market capitalization of $105.97 billion. AppLovin Corporation (NASDAQ:APP) posted a one-month return of -25.71%, while its shares lost 28.07% over the past 52 weeks.
Greenhaven Road Capital stated the following regarding AppLovin Corporation (NASDAQ:APP) in its Q2 2026 investor letter:
"AppLovin Corporation (NASDAQ:APP) — This is a 1% position in a small AI basket. AppLovin is an AI company whose product happens to be ad matching. AXON predicts which ad to show to which user to maximize conversion AppLovin has been one of the best companies at using AI at scale to drive revenues and profits. In 2025 revenue grew ~70% year-over-year to $5.48B with ~82% adjusted EBITDA margin and $3.95B of free cash flow (FCF), an 88% conversion of EBITDA to FCF. In 2025 the company was a rule of 142 company with 70% revenue growth and 72% FCF margin. AppLovin should generate more than $6 million of EBITDA per employee in 2026, paring down headcount while growing at very high rates. Shares trade at sub 20X 2027 FCF."
AppLovin Corporation (NASDAQ:APP) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 91 hedge fund portfolios held AppLovin Corporation (NASDAQ:APP) at the end of the first quarter, compared to 108 in the previous quarter. While we acknowledge the potential of AppLovin Corporation (NASDAQ:APP) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#applovin #company #ebitda
3 months ago
Greenhaven Road Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The fund achieved an approximate 11% net return in the second quarter, indicating progress from the first quarter. Key changes to the portfolio will include lower concentration and increased investments with near-term catalysts, alongside a proactive stance on profit-taking. The focus will remain on owning strong businesses and conducting research that challenges consensus views, as several major investments are poised for significant events within the year. Despite declines in market multiples, underlying businesses continue to grow, suggesting a favorable positioning for returns. Additionally, reviewing the Fund's top five holdings could help identify its best picks for 2026.
In its Q2 2026 investor letter, Greenhaven Road Capital highlighted Lifecore Biomedical, Inc. (NASDAQ:LFCR). Lifecore Biomedical, Inc. (NASDAQ:LFCR) is an integrated contract development and manufacturing organization that engages in the aseptic fill and finish of formulations and highly viscous sterile injectable pharmaceutical drug and medical device products. On August 14, 2026, Lifecore Biomedical, Inc. (NASDAQ:LFCR) closed at $4.72 per share, reflecting a market capitalization of $178.67 million. Lifecore Biomedical, Inc. (NASDAQ:LFCR) posted a one-month return of -3.41%, while its shares lost 38.78% over the past 52 weeks.
Greenhaven Road Capital stated the following regarding Lifecore Biomedical, Inc. (NASDAQ:LFCR) in its Q2 2026 investor letter:
"Another top-five holding is Lifecore Biomedical, Inc. (NASDAQ:LFCR). The entire thesis is that they can sell their excess manufacturing capacity. The company has announced seven new customers in the past nine months, and while the customers are not named specifically, breadcrumbs indicate at least two large customers. For a relatively new CEO and his revamped sales team, this is tangible progress.
Public investors do not appear to fully value Lifecore's contract wins because lengthy FDA approval processes delay the ******* ociated revenue. Yet those approvals also make the contracts exceptionally sticky, a characteristic private investors are typically more willing to value. I continue to believe the shares will trade higher or the company will be sold. A recent SEC filing indicated that the company continues to evaluate a range of strategic alternatives. Insiders own more than 30% of the company, and in most scenarios I model, a sale would occur at a substantial premium to today's share price, potentially more than 100%. In my opinion, there is little to no takeover premium embedded in the price of the stock. Because Alcon's contractual minimums begin in 2027, growth should return in 2027 and accelerate in 2028. Time will tell if the company remains public."
#lifecore #quarter
In its Q2 2026 investor letter, Greenhaven Road Capital highlighted Lifecore Biomedical, Inc. (NASDAQ:LFCR). Lifecore Biomedical, Inc. (NASDAQ:LFCR) is an integrated contract development and manufacturing organization that engages in the aseptic fill and finish of formulations and highly viscous sterile injectable pharmaceutical drug and medical device products. On August 14, 2026, Lifecore Biomedical, Inc. (NASDAQ:LFCR) closed at $4.72 per share, reflecting a market capitalization of $178.67 million. Lifecore Biomedical, Inc. (NASDAQ:LFCR) posted a one-month return of -3.41%, while its shares lost 38.78% over the past 52 weeks.
Greenhaven Road Capital stated the following regarding Lifecore Biomedical, Inc. (NASDAQ:LFCR) in its Q2 2026 investor letter:
"Another top-five holding is Lifecore Biomedical, Inc. (NASDAQ:LFCR). The entire thesis is that they can sell their excess manufacturing capacity. The company has announced seven new customers in the past nine months, and while the customers are not named specifically, breadcrumbs indicate at least two large customers. For a relatively new CEO and his revamped sales team, this is tangible progress.
Public investors do not appear to fully value Lifecore's contract wins because lengthy FDA approval processes delay the ******* ociated revenue. Yet those approvals also make the contracts exceptionally sticky, a characteristic private investors are typically more willing to value. I continue to believe the shares will trade higher or the company will be sold. A recent SEC filing indicated that the company continues to evaluate a range of strategic alternatives. Insiders own more than 30% of the company, and in most scenarios I model, a sale would occur at a substantial premium to today's share price, potentially more than 100%. In my opinion, there is little to no takeover premium embedded in the price of the stock. Because Alcon's contractual minimums begin in 2027, growth should return in 2027 and accelerate in 2028. Time will tell if the company remains public."
#lifecore #quarter
3 months ago
Greenhaven Road Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The fund achieved an approximate 11% net return in the second quarter, indicating progress from the first quarter. Key changes to the portfolio will include lower concentration and increased investments with near-term catalysts, alongside a proactive stance on profit-taking. The focus will remain on owning strong businesses and conducting research that challenges consensus views, as several major investments are poised for significant events within the year. Despite declines in market multiples, underlying businesses continue to grow, suggesting a favorable positioning for returns. Additionally, reviewing the Fund's top five holdings could help identify its best picks for 2026.
In its Q2 2026 investor letter, Greenhaven Road Capital highlighted KKR & Co. Inc. (NYSE:KKR). KKR & Co. Inc. (NYSE:KKR) is a leading private equity and real estate investment firm focusing on direct and fund-of-fund investments. On August 14, 2026, KKR & Co. Inc. (NYSE:KKR) closed at $114.01 per share, reflecting a market capitalization of $102.34 billion. KKR & Co. Inc. (NYSE:KKR) posted a one-month return of 13.58%, while its shares lost 22.00% over the past 52 weeks.
Greenhaven Road Capital stated the following regarding KKR & Co. Inc. (NYSE:KKR) in its Q2 2026 investor letter:
"We still own PAR and KKR & Co. Inc. (NYSE:KKR), but they are not currently top-five holdings, so we will devote more **** e to the new investments. KKR remains a great business. I believe the private credit scare will pass and AUM will march higher, driven by the maturation of existing strategies and the development of the high-net-worth channel."
KKR & Co. Inc. (NYSE:KKR) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 82 hedge fund portfolios held KKR & Co. Inc. (NYSE:KKR) at the end of the first quarter, up from 76 in the previous quarter. While we acknowledge the potential of KKR & Co. Inc. (NYSE:KKR) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#investor
In its Q2 2026 investor letter, Greenhaven Road Capital highlighted KKR & Co. Inc. (NYSE:KKR). KKR & Co. Inc. (NYSE:KKR) is a leading private equity and real estate investment firm focusing on direct and fund-of-fund investments. On August 14, 2026, KKR & Co. Inc. (NYSE:KKR) closed at $114.01 per share, reflecting a market capitalization of $102.34 billion. KKR & Co. Inc. (NYSE:KKR) posted a one-month return of 13.58%, while its shares lost 22.00% over the past 52 weeks.
Greenhaven Road Capital stated the following regarding KKR & Co. Inc. (NYSE:KKR) in its Q2 2026 investor letter:
"We still own PAR and KKR & Co. Inc. (NYSE:KKR), but they are not currently top-five holdings, so we will devote more **** e to the new investments. KKR remains a great business. I believe the private credit scare will pass and AUM will march higher, driven by the maturation of existing strategies and the development of the high-net-worth channel."
KKR & Co. Inc. (NYSE:KKR) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 82 hedge fund portfolios held KKR & Co. Inc. (NYSE:KKR) at the end of the first quarter, up from 76 in the previous quarter. While we acknowledge the potential of KKR & Co. Inc. (NYSE:KKR) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#investor
